Peptide component vaccine engineering: targeting the AIDS virus.
about
Detection of progeny immune responses after intravenous administration of DNA vaccine to pregnant miceRecent advances on the use of structural biology for the design of novel envelope immunogens of HIV-1Induction of antibodies to the human immunodeficiency virus type 1 by immunization of baboons with immunoglobulin molecules carrying the principal neutralizing determinant of the envelope proteinImmunogenic targeting of recombinant peptide vaccines to human antigen-presenting cells by chimeric anti-HLA-DR and anti-surface immunoglobulin D antibody Fab fragments in vitro.Safety and immunogenicity of a CTL multiepitope peptide vaccine for HIV with or without GM-CSF in a phase I trial.Engineered human vaccines.
P2860
Peptide component vaccine engineering: targeting the AIDS virus.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
1990年论文
@zh
1990年论文
@zh-cn
name
Peptide component vaccine engineering: targeting the AIDS virus.
@ast
Peptide component vaccine engineering: targeting the AIDS virus.
@en
type
label
Peptide component vaccine engineering: targeting the AIDS virus.
@ast
Peptide component vaccine engineering: targeting the AIDS virus.
@en
prefLabel
Peptide component vaccine engineering: targeting the AIDS virus.
@ast
Peptide component vaccine engineering: targeting the AIDS virus.
@en
P2860
P1476
Peptide component vaccine engineering: targeting the AIDS virus.
@en
P2093
P2860
P304
P356
10.3109/08830189009061767
P577
1990-01-01T00:00:00Z